Literature DB >> 18726776

Waiting to be born: the ethical implications of the generation of "NUBorn" and "NUAge" mice from pre-pubertal ovarian tissue.

Laurie Zoloth1, Leilah Backhus, Teresa Woodruff.   

Abstract

Oncofertility is one of the 9 NIH Roadmap Initiatives, federal grants intended to explore previously intractable questions, and it describes a new field that exists in the liminal space between cancer treatment and its sequelae, IVF clinics and their yearning, and basic research in cell growth, biomaterials, and reproductive science and its tempting promises. Cancer diagnoses, which were once thought universally fatal, now often entail management of a chronic disease. Yet the therapies are rigorous, must start immediately, and in many cases result in premature failure of the body's reproductive ability. In women, this loss is especially poignant; unlike the routine storage of sperm, which is done in men and boys facing similar treatment decisions, freezing oocytes in anticipation of fertility loss is not possible in most cases, and creating an embryo within days of diagnosis raises significant moral, social and medical challenges. Oncofertility is the study of how to harvest ovarian tissue in women facing cancer to preserve their gametes for future use with IVF, thus allowing the decisions about childbearing to be deferred and reproductive choices to be preserved. The research endeavor uses the capacity of the ovarian follicle to produce eggs in vitro. Developing the human follicle to ovulate successfully outside the body is scientifically difficult and ethically challenging. Infertility is linked to long-standing religious and moral traditions, and is intertwined with deeply contentious social narratives about women, families, illness and birth. Is the research morally permissible? Perhaps imperative if understood as a repair from iatrogenic harms? How are considerations of justice central to the work? How will vulnerable subjects be protected? What are the moral implications of the work for women, children and families? What are the implications for society if women could store ovarian tissue as a way of stopping the biological clock? What are the moral possibilities and challenges if eggs can be produced in large quantities from a stored ovarian tissue?

Entities:  

Mesh:

Year:  2008        PMID: 18726776      PMCID: PMC2908301          DOI: 10.1080/15265160802248203

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  9 in total

1.  Bioethics at the bench.

Authors: 
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

2.  Fair payment or undue inducement?

Authors:  Insoo Hyun
Journal:  Nature       Date:  2006-08-10       Impact factor: 49.962

Review 3.  Ovarian tissue and oocyte cryopreservation.

Authors: 
Journal:  Fertil Steril       Date:  2006-11       Impact factor: 7.329

4.  Early stages of fertilization in vitro of human oocytes matured in vitro.

Authors:  R G Edwards; B D Bavister; P C Steptoe
Journal:  Nature       Date:  1969-02-15       Impact factor: 49.962

5.  Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth.

Authors:  Anjani Chandra; Gladys M Martinez; William D Mosher; Joyce C Abma; Jo Jones
Journal:  Vital Health Stat 23       Date:  2005-12

6.  Tissue-engineered follicles produce live, fertile offspring.

Authors:  Min Xu; Pamela K Kreeger; Lonnie D Shea; Teresa K Woodruff
Journal:  Tissue Eng       Date:  2006-10

7.  Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  1995-02       Impact factor: 7.124

Review 8.  Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents.

Authors:  Carrie L Nieman; Karen E Kinahan; Susan E Yount; Sarah K Rosenbloom; Kathleen J Yost; Elizabeth A Hahn; Timothy Volpe; Kimberley J Dilley; Laurie Zoloth; Teresa K Woodruff
Journal:  Cancer Treat Res       Date:  2007

9.  The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.

Authors: 
Journal:  J Am Coll Dent       Date:  2014
  9 in total
  9 in total

1.  A small field for fertile science: the low visibility of reproductive science in high impact journals.

Authors:  Francesca E Duncan; Benjamin Derman; Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2014-03-21       Impact factor: 3.412

2.  Using decision trees to enhance interdisciplinary team work: the case of oncofertility.

Authors:  Shauna L Gardino; Jacqueline S Jeruss; Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2010-04-13       Impact factor: 3.412

Review 3.  Clinical guide to fertility preservation in hematopoietic cell transplant recipients.

Authors:  S Joshi; B N Savani; E J Chow; M H Gilleece; J Halter; D A Jacobsohn; J Pidala; G P Quinn; J-Y Cahn; A A Jakubowski; N R Kamani; H M Lazarus; J D Rizzo; H C Schouten; G Socie; P Stratton; M L Sorror; A B Warwick; J R Wingard; A W Loren; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

Review 4.  Whose future is it? Ethical family decision making about daughters' treatment in the oncofertility context.

Authors:  Kathleen M Galvin; Marla L Clayman
Journal:  Cancer Treat Res       Date:  2010

Review 5.  Participation in investigational fertility preservation research: a feminist research ethics approach.

Authors:  Michelle L McGowan
Journal:  Cancer Treat Res       Date:  2010

Review 6.  The Oncofertility Consortium--addressing fertility in young people with cancer.

Authors:  Teresa K Woodruff
Journal:  Nat Rev Clin Oncol       Date:  2010-05-25       Impact factor: 66.675

7.  Preserving the right to future children: an ethical case analysis.

Authors:  Gwendolyn P Quinn; Daniel K Stearsman; Lisa Campo-Engelstein; Devin Murphy
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

8.  From the bench to bedside to babies: translational medicine made possible by funding multidisciplinary team science.

Authors:  Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2013-08-23       Impact factor: 3.412

9.  Ethics of fertility preservation for prepubertal children: should clinicians offer procedures where efficacy is largely unproven?

Authors:  Rosalind J McDougall; Lynn Gillam; Clare Delany; Yasmin Jayasinghe
Journal:  J Med Ethics       Date:  2017-10-30       Impact factor: 2.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.